Related Experiment Videos
[AIDS and opportunistic visceral mycoses. A diagnostic and therapeutic update]
1Dipartimento di Medicina Clinica Specialistica e Sperimentale, Università, Bologna.
Recenti Progressi in Medicina
|February 10, 1999
Abstract:
Candidiasis, cryptococcosis, aspergillosis, histoplasmosis, and coccidioidomycosis are the most commonly recognized visceral mycoses complicating the course of HIV infection and AIDS. Their current management issues are discussed on the ground of the personal experience, and the most recent literature evidences.
Insights
Visceral mycoses like candidiasis and cryptococcosis are common in HIV/AIDS. This review covers current management challenges and recent evidence for these fungal infections.
Area of Science:
- Mycology
- Infectious Diseases
- Immunocompromised Host
Context:
- Human Immunodeficiency Virus (HIV) infection and Acquired Immunodeficiency Syndrome (AIDS) significantly increase susceptibility to opportunistic fungal infections.
- Visceral mycoses, particularly candidiasis, cryptococcosis, aspergillosis, histoplasmosis, and coccidioidomycosis, represent major complications in patients with advanced HIV/AIDS.
- Effective management of these invasive fungal infections is critical for improving patient outcomes and survival rates in this population.
Purpose:
- To review the current management strategies for common visceral mycoses in the context of HIV/AIDS.
- To highlight challenges and recent advancements in the diagnosis and treatment of these opportunistic infections.
- To synthesize personal clinical experience with current literature evidence for a comprehensive overview.
Summary:
- Discusses five key visceral mycoses: candidiasis, cryptococcosis, aspergillosis, histoplasmosis, and coccidioidomycosis, frequently observed in HIV/AIDS patients.
- Examines contemporary issues in managing these invasive fungal infections, drawing upon both clinical experience and recent scientific literature.
- Provides insights into the complexities of treating disseminated fungal diseases in individuals with compromised immune systems.
Impact:
- Aims to inform clinicians on best practices for managing invasive fungal infections in HIV/AIDS patients.
- Contributes to the understanding of disease progression and treatment efficacy for mycoses in immunocompromised individuals.
- Supports the development of improved therapeutic guidelines and patient care protocols for opportunistic mycoses.